Elizabeth C Wick1, Cynthia L Sears. 1. Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Abstract
PURPOSE OF REVIEW: The purpose of this review is to describe recent progress in the understanding of the role of Bacteroides spp. in human diarrheal diseases and newer murine studies implicating certain Bacteroides spp. in colorectal cancer. RECENT FINDINGS: Bacteroides fragilis is the only strain of Bacteroides spp. associated with diarrheal disease. Toxin-producing strains of B. fragilis, termed enterotoxigenic Bacteroides fragilis (ETBF), are an established cause of diarrheal disease in people. The clinical syndrome associated with ETBF diarrheal disease encompasses abdominal pain, tenesmus and inflammatory diarrhea. Two new studies conducted in mice have further defined the chronic inflammatory response associated with ETBF infection and observed that in the multiple intestinal neoplasia mouse strain, heterozygotes for the adenomatous polyposis coli gene, ETBF infection enhances development of colonic tumors. Separate murine studies have begun to define the role of nontoxin-producing B. fragilis as a symbiont, serving possibly to protect the host from colonic inflammation. SUMMARY: B. fragilis remains the leading anaerobe in human disease. ETBF is emerging as an important cause of human diarrheal disease but additional epidemiologic studies are needed to better understand the role of ETBF human disease.
PURPOSE OF REVIEW: The purpose of this review is to describe recent progress in the understanding of the role of Bacteroides spp. in humandiarrheal diseases and newer murine studies implicating certain Bacteroides spp. in colorectal cancer. RECENT FINDINGS:Bacteroides fragilis is the only strain of Bacteroides spp. associated with diarrheal disease. Toxin-producing strains of B. fragilis, termed enterotoxigenic Bacteroides fragilis (ETBF), are an established cause of diarrheal disease in people. The clinical syndrome associated with ETBF diarrheal disease encompasses abdominal pain, tenesmus and inflammatory diarrhea. Two new studies conducted in mice have further defined the chronic inflammatory response associated with ETBFinfection and observed that in the multiple intestinal neoplasiamouse strain, heterozygotes for the adenomatous polyposis coli gene, ETBFinfection enhances development of colonic tumors. Separate murine studies have begun to define the role of nontoxin-producing B. fragilis as a symbiont, serving possibly to protect the host from colonic inflammation. SUMMARY:B. fragilis remains the leading anaerobe in human disease. ETBF is emerging as an important cause of humandiarrheal disease but additional epidemiologic studies are needed to better understand the role of ETBFhuman disease.
Authors: Ju Young Chang; Dionysios A Antonopoulos; Apoorv Kalra; Adriano Tonelli; Walid T Khalife; Thomas M Schmidt; Vincent B Young Journal: J Infect Dis Date: 2008-02-01 Impact factor: 5.226
Authors: Cynthia L Sears; Salequl Islam; Amit Saha; Maleka Arjumand; Nur Haque Alam; A S G Faruque; M A Salam; Jai Shin; David Hecht; Andrej Weintraub; R Bradley Sack; Firdausi Qadri Journal: Clin Infect Dis Date: 2008-09-15 Impact factor: 9.079
Authors: Elizabeth K Costello; Christian L Lauber; Micah Hamady; Noah Fierer; Jeffrey I Gordon; Rob Knight Journal: Science Date: 2009-11-05 Impact factor: 47.728
Authors: Johanna von Gerichten; Dominic Lamprecht; Lukáš Opálka; Daphnée Soulard; Christian Marsching; Robert Pilz; Valentin Sencio; Silke Herzer; Bruno Galy; Viola Nordström; Carsten Hopf; Hermann-Josef Gröne; François Trottein; Roger Sandhoff Journal: J Lipid Res Date: 2019-09-04 Impact factor: 5.922
Authors: Agnieszka Szymula; Jacob Rosenthal; Barbara M Szczerba; Harini Bagavant; Shu Man Fu; Umesh S Deshmukh Journal: Clin Immunol Date: 2014-02-19 Impact factor: 3.969
Authors: Sergey A Shiryaev; Albert G Remacle; Andrei V Chernov; Vladislav S Golubkov; Khatereh Motamedchaboki; Norihito Muranaka; Corey M Dambacher; Petr Capek; Muskan Kukreja; Igor A Kozlov; Manuel Perucho; Piotr Cieplak; Alex Y Strongin Journal: J Biol Chem Date: 2013-10-21 Impact factor: 5.157